FDA
-
-
-
-
-
-
-
MiniMed Delivers Strong Fourth Quarter and Full Fiscal Year 2026 Financial Results; Provides Fiscal Year 2027 Outlook
-
-
-
-
-
-
-
Mind Medicine (MNMD) Announces Business Update and Anticipated Milestones for 2024
-
-
-
-
-
-
-
MindMed Appoints Francois Lilienthal, MD as Chief Commercial Officer
-
-
-
-
-
-
-
MindMed Appoints Dr. Robert Dworkin to Scientific Advisory Board
-
-
-
-
-
-
-
MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company
-
-
-
-
-
-
-
Phase 2 Clinical Trial of LSD for "Suicide Headaches" Begins Treating Patients
-
-
325,876 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

